Comparison of the efficacy of different doses of buprenorphine (8mg, 2mg) on the reduction of methamphetamine(crystal, Shishe) withdrawal symptoms, depression, suicidal thought and anxiety
Not Applicable
Recruiting
- Conditions
- Methamphetamine Dependency.Mental and behavioural disorders due to use of other stimulants, including caffeine
- Registration Number
- IRCT2017081525160N8
- Lead Sponsor
- Shiraz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Male
- Target Recruitment
- 66
Inclusion Criteria
Age: 18-60 ;informed consent; methamphetamine dependence Exclusion criteria:Patients unwilling to participate at beginning or during the study; use of another substance except Methamphetamine as of the main substance.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Craving, depression, suicidal thoughts and anxiety. Timepoint: Daily for 5 days. Method of measurement: Questionnaire and interview.
- Secondary Outcome Measures
Name Time Method